
875 Research Parkway
Meriden, CT 06450
Phone: 815-519-7834
Website: https://livitah.com
General Information:
Livita Life Sciences’ NanoBioglass represents a significant morphological advancement in biomaterials for bone tissue repair and injury treatment in Orthopedics and Dentistry Segments. By applying nanotechnology to Bioglass production, Livita Life Sciences, in collaboration with its associated researchers, has achieved an approximately 99% reduction in particle size compared to leading market competitors. This reduction directly influences the cascade of biological processes involved in bone regeneration. Perfectly spherical nanoparticles exhibit a higher surface area, facilitating more rapid and controlled dissolution, as well as the efficient release of calcium and phosphorus ions.These conditions promote the formation of hydroxyapatite, a key component in the osseointegration process.
Research Activities:
Development of bioactive glass nanoparticles (BGNs) for bone regeneration and localized drug delivery. Activities include controlled synthesis and functionalization of mesoporous nanoparticles to promote hydroxyapatite formation, enhance osteogenesis, and enable loading and controlled release of chemotherapeutic agents for bone cancer treatment. Research also involves incorporation into scaffolds or injectable systems and physicochemical and biological characterization for translational applications.